The Clinicopathological Significance of Epithelial Mesenchymal Transition Associated Protein Expression in Head and Neck Squamous Cell Carcinoma

Overview

Journal Korean J Pathol

Specialty Pathology

Date 2014 Sep 13

PMID 25214857

Citations 7

Authors

Kyu Ho Kim

Lucia Kim

Suk Jin Choi

Jee Young Han

Joon Mee Kim

Young Chae Chu

Young-Mo Kim

In Suh Park

Joo Han Lim

Affiliations

Soon will be listed here.

Abstract

Background: Epithelial mesenchymal transition (EMT) has an important role in invasion and metastasis of tumor cells. The purpose of this study was to evaluate the roles of EMT-associated proteins on progression and metastasis as a prognostic/predictive factor in curatively-resected (R0) head and neck squamous cell carcinoma (HNSCC).

Methods: A total of 118 patients who received curative surgery for HNSCC at Inha University Hospital between January 1996 and December 2011 were included. We used protein immunohistochemistry to evaluate the expression of E-cadherin, vimentin, and EZH2 on tissue microarrays. Also, we reviewed all medical records and analyzed the relationship between the expression of EMT-associated proteins and prognosis.

Results: The E-cadherin-negative group showed more moderate/poor differentiation of cancer cell type than the higher E-cadherin-expressing group (p=.016) and high EZH2 expression was significantly correlated with nodal metastasis (p=.012). Our results demonstrate a significant association between high expression of EZH2 and vimentin and presence of distant progression (p=.026). However, expression of E-cadherin, vimentin, and EZH2 was not significantly associated with overall survival.

Conclusions: These findings suggest that an EMT-associated protein expression profile is correlated with aggressiveness of disease and prognosis, and could be a useful marker for determination of additional treatment in curatively-resected HNSCC patients.

Citing Articles

Enhanced Expression of N-Cadherin, but Not of E-Cadherin, in Cutaneous Squamous Cell Carcinoma in Comparison to Basal Cell Carcinoma.

Pogorzelska-Dyrbus J, Nowicka-Suszko D, Piotrowska A, Wozniak Z, Dziegiel P, Szepietowski J Cancers (Basel). 2025; 16(24.

PMID: 39766148 PMC: 11674879. DOI: 10.3390/cancers16244247.

Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma.

Cheng Y, Song Z, Fang X, Tang Z Clin Epigenetics. 2024; 16(1):54.

PMID: 38600608 PMC: 11007890. DOI: 10.1186/s13148-024-01666-2.

The potential of EZH2 expression to facilitate treatment choice in stage II colorectal adenocarcinoma.

Zhu X, He L, Zheng Z, Wang Y, Yang J, Zhang B Histol Histopathol. 2024; 39(10):1371-1379.

PMID: 38567631 DOI: 10.14670/HH-18-732.

MiR-876-5p modulates head and neck squamous cell carcinoma metastasis and invasion by targeting vimentin.

Dong Y, Zheng Y, Wang C, Ding X, Du Y, Liu L Cancer Cell Int. 2018; 18:121.

PMID: 30181714 PMC: 6114268. DOI: 10.1186/s12935-018-0619-7.

Loss of ACVRIB leads to increased squamous cell carcinoma aggressiveness through alterations in cell-cell and cell-matrix adhesion proteins.

Loomans H, Arnold S, Hebron K, Taylor C, Zijlstra A, Andl C Am J Cancer Res. 2018; 7(12):2422-2437.

PMID: 29312797 PMC: 5752684.

References

Pyo S, Hashimoto M, Kim Y, Kim C, Lee S, Johnson K . Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome. J Craniomaxillofac Surg. 2007; 35(1):1-9. DOI: 10.1016/j.jcms.2006.11.004. View

Liu M, Scanlon C, Banerjee R, Russo N, Inglehart R, Willis A . The Histone Methyltransferase EZH2 Mediates Tumor Progression on the Chick Chorioallantoic Membrane Assay, a Novel Model of Head and Neck Squamous Cell Carcinoma. Transl Oncol. 2013; 6(3):273-81. PMC: 3660795. DOI: 10.1593/tlo.13175. View

Nijkamp M, Span P, Hoogsteen I, van der Kogel A, Kaanders J, Bussink J . Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. Radiother Oncol. 2011; 99(3):344-8. DOI: 10.1016/j.radonc.2011.05.066. View

Diniz-Freitas M, Garcia-Caballero T, Antunez-Lopez J, Gandara-Rey J, Garcia-Garcia A . Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol. 2005; 42(2):190-200. DOI: 10.1016/j.oraloncology.2005.07.010. View

Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2011; 127(12):2893-917. DOI: 10.1002/ijc.25516. View

Thiery J . Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002; 2(6):442-54. DOI: 10.1038/nrc822. View

Thiery J, Acloque H, Huang R, Nieto M . Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139(5):871-90. DOI: 10.1016/j.cell.2009.11.007. View

Breuer R, Snijders P, Smit E, Sutedja T, Sewalt R, Otte A . Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis. Neoplasia. 2005; 6(6):736-43. PMC: 1531677. DOI: 10.1593/neo.04160. View

Ukpo O, Thorstad W, Zhang Q, Lewis Jr J . Lack of association of cadherin expression and histopathologic type, metastasis, or patient outcome in oropharyngeal squamous cell carcinoma: a tissue microarray study. Head Neck Pathol. 2011; 6(1):38-47. PMC: 3311946. DOI: 10.1007/s12105-011-0306-7. View

10.

Liu L, Jiang X, Zhou X, Wang D, Song X, Jiang H . Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome. Mod Pathol. 2009; 23(2):213-24. DOI: 10.1038/modpathol.2009.160. View

11.

Weikert S, Christoph F, Kollermann J, Muller M, Schrader M, Miller K . Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas. Int J Mol Med. 2005; 16(2):349-53. View

12.

Wang C, Liu X, Chen Z, Huang H, Jin Y, Kolokythas A . Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma. Mol Carcinog. 2011; 52(3):229-36. PMC: 3400713. DOI: 10.1002/mc.21848. View

13.

Thiery J, Sleeman J . Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006; 7(2):131-42. DOI: 10.1038/nrm1835. View

14.

Kim H, Yoo S, Sun P, Jin Y, Jheon S, Lee C . Alteration of the E-Cadherin/β-Catenin Complex Is an Independent Poor Prognostic Factor in Lung Adenocarcinoma. Korean J Pathol. 2013; 47(1):44-51. PMC: 3589608. DOI: 10.4132/KoreanJPathol.2013.47.1.44. View

15.

Tan J, Yang X, Zhuang L, Jiang X, Chen W, Lee P . Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 2007; 21(9):1050-63. PMC: 1855231. DOI: 10.1101/gad.1524107. View

16.

Myong N . Loss of E-cadherin and Acquisition of Vimentin in Epithelial-Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression. Korean J Pathol. 2012; 46(4):341-8. PMC: 3479821. DOI: 10.4132/KoreanJPathol.2012.46.4.341. View

17.

Bachmann I, Halvorsen O, Collett K, Stefansson I, Straume O, Haukaas S . EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol. 2005; 24(2):268-73. DOI: 10.1200/JCO.2005.01.5180. View

18.

Ueda G, Sunakawa H, Nakamori K, Shinya T, Tsuhako W, Tamura Y . Aberrant expression of beta- and gamma-catenin is an independent prognostic marker in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2005; 35(4):356-61. DOI: 10.1016/j.ijom.2005.07.023. View

19.

Holland D, Hoppe-Seyler K, Schuller B, Lohrey C, Maroldt J, Durst M . Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein. Cancer Res. 2008; 68(23):9964-72. DOI: 10.1158/0008-5472.CAN-08-1134. View